These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 12517251)

  • 21. Infliximab for juvenile idiopathic arthritis-associated uveitis.
    Richards JC; Tay-Kearney ML; Murray K; Manners P
    Clin Exp Ophthalmol; 2005 Oct; 33(5):461-8. PubMed ID: 16181269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current treatment of juvenile rheumatoid arthritis.
    Ilowite NT
    Pediatrics; 2002 Jan; 109(1):109-15. PubMed ID: 11773549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [BIOLOGIC THERAPY FOR JUVENILE IDIOPATHIC ARTHRITIS].
    Brik R
    Harefuah; 2017 Oct; 156(10):659-662. PubMed ID: 29072387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New drugs and treatment strategies for rheumatoid arthritis].
    Fantini F
    Recenti Prog Med; 2003 Sep; 94(9):361-79. PubMed ID: 12942798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. JAMA patient page. Juvenile idiopathic arthritis.
    Chang HJ; Burke AE; Glass RM
    JAMA; 2010 Apr; 303(13):1328. PubMed ID: 20371795
    [No Abstract]   [Full Text] [Related]  

  • 26. Rituximab use in young adults diagnosed with juvenile idiopathic arthritis unresponsive to conventional treatment: report of 6 cases.
    Sakamoto AP; Pinheiro MM; Barbosa CM; Fraga MM; Len CA; Terreri MT
    Rev Bras Reumatol; 2015; 55(6):536-41. PubMed ID: 26066294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of Juvenile Idiopathic Arthritis: A Clinical Guide.
    Blazina Š; Markelj G; Avramovič MZ; Toplak N; Avčin T
    Paediatr Drugs; 2016 Dec; 18(6):397-412. PubMed ID: 27484749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bayesian comparative effectiveness study of four consensus treatment plans for initial management of systemic juvenile idiopathic arthritis: FiRst-Line Options for Systemic juvenile idiopathic arthritis Treatment (FROST).
    Nigrovic PA; Beukelman T; Tomlinson G; Feldman BM; Schanberg LE; Kimura Y;
    Clin Trials; 2018 Jun; 15(3):268-277. PubMed ID: 29542334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations: similarities and differences.
    Favalli EG; Pontikaki I; Becciolini A; Biggioggero M; Ughi N; Romano M; Crotti C; Gattinara M; Gerloni V; Marchesoni A; Meroni PL
    Clin Rheumatol; 2017 Aug; 36(8):1747-1755. PubMed ID: 28597133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrophage activation syndrome as the initial manifestation of systemic onset juvenile idiopathic arthritis.
    Cuende E; Vesga JC; Pérez LB; Ardanaz MT; Guinea J
    Clin Exp Rheumatol; 2001; 19(6):764-5. PubMed ID: 11791663
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug treatment in children with juvenile rheumatoid arthritis. Past, present, and future.
    Giannini EH; Cawkwell GD
    Pediatr Clin North Am; 1995 Oct; 42(5):1099-125. PubMed ID: 7567188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiologic Improvement of juvenile idiopathic arthritis-enthesitis-related arthritis following anti-tumor necrosis factor-alpha blockade with etanercept.
    Tse SM; Laxer RM; Babyn PS; Doria AS
    J Rheumatol; 2006 Jun; 33(6):1186-8. PubMed ID: 16755667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Biological therapy treatment of juvenile idiopathic arthritis].
    Herlin T
    Ugeskr Laeger; 2008 Jun; 170(24):2105-8. PubMed ID: 18565289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Juvenile rheumatoid arthritis: therapeutic perspectives.
    Chikanza IC
    Paediatr Drugs; 2002; 4(5):335-48. PubMed ID: 11994038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of juvenile idiopathic arthritis in the biologic age.
    Stoll ML; Cron RQ
    Rheum Dis Clin North Am; 2013 Nov; 39(4):751-66. PubMed ID: 24182853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Etanercept improves lipid profile and oxidative stress measures in patients with juvenile idiopathic arthritis.
    De Sanctis S; Marcovecchio ML; Gaspari S; Del Torto M; Mohn A; Chiarelli F; Breda L
    J Rheumatol; 2013 Jun; 40(6):943-8. PubMed ID: 23547210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effect of Tumor Necrosis Factor α Blockers on Growth Velocity in Juvenile Idiopathic Arthritis.
    Mrážik P; Vargová V; Košková E
    J Clin Rheumatol; 2015 Oct; 21(7):376-8. PubMed ID: 26398470
    [No Abstract]   [Full Text] [Related]  

  • 38. Low-dose methotrexate treatment for oligoarticular juvenile idiopathic arthritis nonresponsive to intra-articular corticosteroids.
    Brik R; Gepstein V; Berkovitz D
    Clin Rheumatol; 2005 Nov; 24(6):612-4. PubMed ID: 15877178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological management of juvenile rheumatoid arthritis.
    Rose CD; Doughty RA
    Drugs; 1992 Jun; 43(6):849-63. PubMed ID: 1379157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in medication usage in juvenile idiopathic arthritis: prescribing trends or trends in prescribers?
    Levy D
    J Rheumatol; 2014 Oct; 41(10):1903-5. PubMed ID: 25275091
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.